Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

  • There is currently no data for MXCT

MaxCyte News

MaxCyte announces new CEO, updates revenue guidance
12 Dec 2023

MaxCyte announces new CEO, updates revenue guidance

(Sharecast News) - Cell engineering technology specialist MaxCyte announced a significant chief executive transition on Tuesday and updated its revenu...

MaxCyte joins Alliance for mRNA Medicines
16 Nov 2023

MaxCyte joins Alliance for mRNA Medicines

(Sharecast News) - Cell engineering company MaxCyte announced its membership in the Alliance for mRNA Medicines (AMM) as a founding member on Thursday...

EARNINGS AND TRADING: Chapel Down hopes to make splash on AIM
9 Nov 2023

EARNINGS AND TRADING: Chapel Down hopes to make splash on AIM

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

MaxCyte lowers full-year guidance after weaker third quarter
5 Oct 2023

MaxCyte lowers full-year guidance after weaker third quarter

(Sharecast News) - Cell engineering specialist MaxCyte revised its full-year guidance downwards on Thursday based on its preliminary third-quarter rev...

AIM WINNERS & LOSERS: SDX Energy receives gas prepayment from Citic
5 Oct 2023

AIM WINNERS & LOSERS: SDX Energy receives gas prepayment from Citic

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

MaxCyte shares fall as warns of sharp revenue drop, citing volatility
5 Oct 2023

MaxCyte shares fall as warns of sharp revenue drop, citing volatility

(Alliance News) - MaxCyte Inc on Thursday said it expects revenue in the third quarter and for all of 2023 to fall from a year before, citing volatili...

MaxCyte shares fall as revenue plummets in first half, loss widens
10 Aug 2023

MaxCyte shares fall as revenue plummets in first half, loss widens

(Alliance News) - MaxCyte Inc on Thursday reported an increased loss in the first half of 2023, as revenue fell while costs increased.